Literature DB >> 24297504

Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints.

Agnese Picco1, M Cristina Polidori, Michela Ferrara, Roberta Cecchetti, Dario Arnaldi, Mauro Baglioni, Silvia Morbelli, Patrizia Bastiani, Irene Bossert, Giuliana Fiorucci, Andrea Brugnolo, Massimo Eugenio Dottorini, Flavio Nobili, Patrizia Mecocci.   

Abstract

PURPOSE: The role of oxidative stress is increasingly recognized in cognitive disorders of the elderly, notably Alzheimer's disease (AD). In these subjects brain(18)F-FDG PET is regarded as a reliable biomarker of neurodegeneration. We hypothesized that oxidative stress could play a role in impairing brain glucose utilization in elderly subjects with increasing severity of cognitive disturbance.
METHODS: The study group comprised 85 subjects with cognitive disturbance of increasing degrees of severity including 23 subjects with subjective cognitive impairment (SCI), 28 patients with mild cognitive impairment and 34 patients with mild AD. In all subjects brain FDG PET was performed and plasma activities of extracellular superoxide dismutase (eSOD), catalase and glutathione peroxidase were measured. Voxel-based analysis (SPM8) was used to compare FDG PET between groups and to evaluate correlations between plasma antioxidants and glucose metabolism in the whole group of subjects, correcting for age and Mini-Mental State Examination score.
RESULTS: Brain glucose metabolism progressively decreased in the bilateral posterior temporoparietal and cingulate cortices across the three groups, from SCI to mild AD. eSOD activity was positively correlated with glucose metabolism in a large area of the left temporal lobe including the superior, middle and inferior temporal gyri and the fusiform gyrus.
CONCLUSION: These results suggest a role of oxidative stress in the impairment of glucose utilization in the left temporal lobe structures in elderly patients with cognitive abnormalities, including AD and conditions predisposing to AD. Further studies exploring the oxidative stress-energy metabolism axis are considered worthwhile in larger groups of these patients in order to identify pivotal pathophysiological mechanisms and innovative therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297504     DOI: 10.1007/s00259-013-2638-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  59 in total

Review 1.  Delaying the mitochondrial decay of aging.

Authors:  Bruce N Ames
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

2.  Chronological primacy of oxidative stress in Alzheimer disease.

Authors:  Mark A Smith; Akihiko Nunomura; Hyoung-gon Lee; Xiongwei Zhu; Paula I Moreira; Jesús Avila; George Perry
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

3.  Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.

Authors:  Silvia Morbelli; Alex Drzezga; Robert Perneczky; Giovanni B Frisoni; Anna Caroli; Bart N M van Berckel; Rik Ossenkoppele; Eric Guedj; Mira Didic; Andrea Brugnolo; Gianmario Sambuceti; Marco Pagani; Eric Salmon; Flavio Nobili
Journal:  Neurobiol Aging       Date:  2012-02-23       Impact factor: 4.673

4.  Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly.

Authors:  Priya Rajagopalan; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Neuroreport       Date:  2013-01-23       Impact factor: 1.837

Review 5.  Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.

Authors:  E Mariani; M C Polidori; A Cherubini; P Mecocci
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-23       Impact factor: 3.205

6.  Reduction in extracellular superoxide dismutase activity in African-American patients with hypertension.

Authors:  LiChun Zhou; Wei Xiang; James Potts; Michael Floyd; Chakradhari Sharan; Hong Yang; Joan Ross; Alfred M Nyanda; ZhongMao Guo
Journal:  Free Radic Biol Med       Date:  2006-07-27       Impact factor: 7.376

7.  Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells.

Authors:  Alberto Gómez-Ramos; Javier Díaz-Nido; Mark A Smith; George Perry; Jesús Avila
Journal:  J Neurosci Res       Date:  2003-03-15       Impact factor: 4.164

8.  Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology.

Authors:  Beatrice Terni; Jordi Boada; Manuel Portero-Otin; Reinald Pamplona; Isidro Ferrer
Journal:  Brain Pathol       Date:  2009-02-27       Impact factor: 6.508

Review 9.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

10.  Diagnostic evaluation of degenerative and vascular dementia.

Authors:  C Loeb; C Gandolfo
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

View more
  9 in total

Review 1.  Amyloid positron emission tomography and cognitive reserve.

Authors:  Matteo Bauckneht; Agnese Picco; Flavio Nobili; Silvia Morbelli
Journal:  World J Radiol       Date:  2015-12-28

2.  Early identification of MCI converting to AD: a FDG PET study.

Authors:  Marco Pagani; Flavio Nobili; Silvia Morbelli; Dario Arnaldi; Alessandro Giuliani; Johanna Öberg; Nicola Girtler; Andrea Brugnolo; Agnese Picco; Matteo Bauckneht; Roberta Piva; Andrea Chincarini; Gianmario Sambuceti; Cathrine Jonsson; Fabrizio De Carli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-29       Impact factor: 9.236

Review 3.  Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview.

Authors:  Angelica Varesi; Adelaide Carrara; Vitor Gomes Pires; Valentina Floris; Elisa Pierella; Gabriele Savioli; Sakshi Prasad; Ciro Esposito; Giovanni Ricevuti; Salvatore Chirumbolo; Alessia Pascale
Journal:  Cells       Date:  2022-04-17       Impact factor: 7.666

Review 4.  Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease.

Authors:  Alexander Drzezga; Daniele Altomare; Cristina Festari; Javier Arbizu; Stefania Orini; Karl Herholz; Peter Nestor; Federica Agosta; Femke Bouwman; Flavio Nobili; Zuzana Walker; Giovanni Battista Frisoni; Marina Boccardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-13       Impact factor: 9.236

Review 5.  A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.

Authors:  Patrizia Mecocci; Virginia Boccardi; Roberta Cecchetti; Patrizia Bastiani; Michela Scamosci; Carmelinda Ruggiero; Marta Baroni
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Serum Uric Acid, Alzheimer-Related Brain Changes, and Cognitive Impairment.

Authors:  Jee Wook Kim; Min Soo Byun; Dahyun Yi; Jun Ho Lee; So Yeon Jeon; Kang Ko; Gijung Jung; Han Na Lee; Jun-Young Lee; Chul-Ho Sohn; Yun-Sang Lee; Seong A Shin; Yu Kyeong Kim; Dong Young Lee
Journal:  Front Aging Neurosci       Date:  2020-06-05       Impact factor: 5.750

Review 7.  The Hidden Notes of Redox Balance in Neurodegenerative Diseases.

Authors:  Silvia Piccirillo; Simona Magi; Alessandra Preziuso; Tiziano Serfilippi; Giorgia Cerqueni; Monia Orciani; Salvatore Amoroso; Vincenzo Lariccia
Journal:  Antioxidants (Basel)       Date:  2022-07-26

Review 8.  Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease.

Authors:  Virginia Boccardi; Marta Baroni; Francesca Mangialasche; Patrizia Mecocci
Journal:  Alzheimers Dement (N Y)       Date:  2016-08-30

9.  Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Virginia Boccardi; Eric Westman; Luca Pelini; Olof Lindberg; J-Sebastian Muehlboeck; Andrew Simmons; Roberto Tarducci; Piero Floridi; Pietro Chiarini; Hilkka Soininen; Iwona Kloszewska; Magda Tsolaki; Bruno Vellas; Christian Spenger; Lars-Olof Wahlund; Simon Lovestone; Patrizia Mecocci
Journal:  Front Aging Neurosci       Date:  2019-01-17       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.